TAIM
AGN

TD Ameritrade Investment Management’s Allergan plc AGN Stock Holding History

TD Ameritrade Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed -$2K – 661
2020
Q1 		$2K Sell
10
-18
-64% -$3.39K ﹤0.01% 571
2019
Q4 		$5K Hold
28
– – ﹤0.01% 524
2019
Q3 		$5K Sell
28
-40
-59% -$6.52K ﹤0.01% 536
2019
Q2 		$11K Buy
68
+9
+15% +$1.25K ﹤0.01% 385
2019
Q1 		$9K Buy
59
+7
+13% +$1.01K ﹤0.01% 374
2018
Q4 		$7K Buy
52
+40
+333% +$6.56K ﹤0.01% 419
2018
Q3 		$2K Buy
12
+10
+500% +$1.84K ﹤0.01% 516
2018
Q2 		$0 Buy
+2
New +$321 ﹤0.01% 473

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

TD Ameritrade Investment Management's AGN Position: Q2 2020 in Review

TD Ameritrade Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10 shares — an estimated $2K sold.

TD Ameritrade Investment Management first reported a position in AGN in Q2 2018 and held it in 8 quarters. The position peaked at $11K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • TD Ameritrade Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 10 Allergan plc shares in Q2 2020, an estimated $2K.
  • TD Ameritrade Investment Management first reported a position in Allergan plc in Q2 2018 and held it in 8 quarters.
  • TD Ameritrade Investment Management's Allergan plc position peaked at $11K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on TD Ameritrade Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.